Relative potency of bicalutamide (Casodex) and flutamide (Eulexin) [4] (multiple letters)

Urology

Volumn 54, Issue 1, 1999, Pages 194-197

  Kolvenbag, G J C M ^a   Furr, B J A ^a   Labrie, F ^a   Simard, J ^a   Coquet, A ^a   Lablanc, G ^a   Candas, B ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; FLUTAMIDE; GONADORELIN DERIVATIVE; HYDROXYFLUTAMIDE; METRIBOLONE; PROSTATE SPECIFIC ANTIGEN; TRITIUM;

CANCER HORMONE THERAPY; CANCER SURVIVAL; CASTRATION; CLINICAL TRIAL; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGEN ANTAGONISTS; ANILIDES; ANIMALS; FLUTAMIDE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0032996029     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)